An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)
Public ClinicalTrials.gov record NCT00644332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Women's Ischemia Symptom Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
According to the American Heart Association (AHA) 2011 update of heart disease and stroke statistics, more than 9 million adult patients in the United States (US) have angina. This update also notes that a study of 4 national cross-sectional health examination studies found that, among Americans 40 to 74 years of age, the age-adjusted prevalence of angina was higher among women than men. Per ACC/AHA guidelines, the goal of antianginal therapy is the complete or near complete elimination of anginal chest pain and a return to normal activities and functional capacity. However, evaluating angina and responses to antianginal therapy is often not straightforward. This is particularly true of female patients with angina. Because angina and response to antianginal therapy may differ in men and women, an instrument designed specifically to address symptomatology in women with angina could enhance our understanding and characterization of angina and responses to therapy in this population. The current study will evaluate the validity, reliability, and responsiveness of the newly developed Women's Ischemia Symptom Questionnaire (WISQ) based on changes in angina symptomatology in a female angina population treated with ranolazine, compared with the widely used Seattle Angina Questionnaire (SAQ).
Study identification
- NCT ID
- NCT00644332
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 172 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2007 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- Jul 2, 2012
2007 – 2011
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35294-0007 | — |
| Cardiovascular Consultants, Ltd. | Phoenix | Arizona | 85032 | — |
| Cardiology Consultants of Orange County | Anaheim | California | 92801 | — |
| Access Clinical Trials/Cardiovascular Research Institute (ACT/CVRI) | Beverly Hills | California | 90210 | — |
| Escondido Cardiology Associates | Escondido | California | 92025 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Mission Internal Medical Group | Mission Viejo | California | 92691 | — |
| South Denver Cardiology Associates, PC | Littleton | Colorado | 80120-5654 | — |
| Guerra Cardiology | Coral Gables | Florida | 33134 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| St. Luke Cardiology Associates | Jacksonville | Florida | 32216 | — |
| Jacksonville Heart Center, PA | Jacksonville | Florida | 32250 | — |
| Jacksonville Heart Center, PA | Jacksonville | Florida | 32258 | — |
| Emory University & Grady Health System | Atlanta | Georgia | 30303 | — |
| Mercy Physician Group Cardiology | Nampa | Idaho | 83686 | — |
| North Shore Cardiology | Bannockburn | Illinois | 60015 | — |
| Gateway Cardiology, P.C. | Jerseyville | Illinois | 62052 | — |
| Northern Indiana Research Alliance | Fort Wayne | Indiana | 46804 | — |
| Ashland Hospital Corporation d/b/a King's Daughters Medical Center | Ashland | Kentucky | 41101 | — |
| University of Louisville, Division of Cardiovascular Medicine | Louisville | Kentucky | 40202 | — |
| Gateway Cardiology, P.C. | St Louis | Missouri | 63128 | — |
| Integrated Cardiology Consultants, LLC d.b.a. Bryan LGH Heart Institute | Lincoln | Nebraska | 68506 | — |
| Albany Associates in Cardiology | Albany | New York | 12205 | — |
| Total Heart Care, PC | New York | New York | 10128 | — |
| The Lindner Clinical Trial Center | Cincinnati | Ohio | 45219 | — |
| St. Vincent Mercy Medical Center, Cardiac Research | Toledo | Ohio | 43608 | — |
| BlueStem Cardiology | Bartlesville | Oklahoma | 74006 | — |
| Tri-State Medical Group, Cardiology, Sewickley Valley Medical Group, Cardiology | Beaver | Pennsylvania | 15009 | — |
| Cardiology Consultants of Philadelphia | Philadelphia | Pennsylvania | 19111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00644332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2012 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00644332 live on ClinicalTrials.gov.